Key Points
- Globe Life CFO Thomas Peter Kalmbach sold shares twice in early May, including 15,637 shares on May 11 for about $2.4 million and 11,790 shares on May 8 for about $1.79 million.
- After the latest sale, Kalmbach’s direct stake fell by 25.65% to 45,335 shares, valued at roughly $6.97 million.
- Globe Life reported Q1 earnings of $3.43 per share, missing estimates by a penny, while revenue matched expectations at $1.56 billion; the company also announced a quarterly dividend of $0.33 per share.
Globe Life Inc. (NYSE:GL - Get Free Report) CFO Thomas Peter Kalmbach sold 11,790 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $152.02, for a total transaction of $1,792,315.80. Following the completion of the sale, the chief financial officer owned 40,972 shares in the company, valued at $6,228,563.44. The trade was a 22.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.
Thomas Peter Kalmbach also recently made the following trade(s):
- On Monday, May 11th, Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock. The stock was sold at an average price of $153.65, for a total transaction of $2,402,625.05.
Globe Life Stock Up 0.6%
NYSE:GL opened at $154.84 on Wednesday. The firm has a market capitalization of $12.02 billion, a P/E ratio of 10.71 and a beta of 0.50. Globe Life Inc. has a 1-year low of $116.73 and a 1-year high of $156.69. The company's fifty day moving average price is $145.44 and its 200-day moving average price is $140.77. The company has a debt-to-equity ratio of 0.38, a current ratio of 0.07 and a quick ratio of 0.07.
Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts' consensus estimates of $3.46 by ($0.03). The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The firm's revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.07 EPS. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, equities research analysts anticipate that Globe Life Inc. will post 15.53 EPS for the current year.
Globe Life Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life's dividend payout ratio (DPR) is currently 9.13%.
Institutional Trading of Globe Life
Several institutional investors have recently modified their holdings of GL. CYBER HORNET ETFs LLC acquired a new stake in shares of Globe Life in the second quarter valued at about $28,000. Hilton Head Capital Partners LLC acquired a new stake in shares of Globe Life in the fourth quarter valued at about $30,000. MUFG Securities EMEA plc acquired a new stake in shares of Globe Life in the second quarter valued at about $31,000. Quent Capital LLC acquired a new stake in shares of Globe Life in the third quarter valued at about $36,000. Finally, Torren Management LLC acquired a new stake in shares of Globe Life in the fourth quarter valued at about $37,000. Institutional investors and hedge funds own 81.61% of the company's stock.
Analyst Ratings Changes
Several analysts recently commented on GL shares. Truist Financial raised their price target on shares of Globe Life from $180.00 to $185.00 and gave the company a "buy" rating in a research report on Friday, April 24th. Piper Sandler upgraded shares of Globe Life to a "strong-buy" rating in a research report on Thursday, April 2nd. JPMorgan Chase & Co. raised their price target on shares of Globe Life from $180.00 to $181.00 and gave the company an "overweight" rating in a research report on Thursday, February 5th. Evercore set a $157.00 price target on shares of Globe Life in a research report on Wednesday, February 18th. Finally, Wells Fargo & Company raised their price target on shares of Globe Life from $171.00 to $172.00 and gave the company an "overweight" rating in a research report on Friday, April 10th. Two research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $172.67.
Read Our Latest Stock Report on GL
Globe Life Company Profile
(
Get Free Report)
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company's product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
